Integrated Investment Consultants’s GSK GSK Stock Holding History

Integrated Investment Consultants’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-67,544	Closed	-$87K	–	330
2024 Q3	$87K	Buy	+67,544	New	+$2.76M	0.02%	301
2022 Q2	–	Sell	-9,988	Closed	-$544K	–	274
2022 Q1	$544K	Buy	9,988 +802	+9%	+$43.6K	0.15%	115
2021 Q4	$506K	Buy	9,186 +45	+0.5%	+$2.34K	0.14%	134
2021 Q3	$437K	Sell	9,141 -2,335	-20%	-$117K	0.13%	141
2021 Q2	$571K	Buy	+11,476	New	+$551K	0.17%	111
2018 Q2	–	Sell	-2,544	Closed	-$124K	–	388
2018 Q1	$124K	Buy	+2,544	New	+$118K	0.05%	279
2017 Q3	$112K	Hold	2,216	–	–	0.05%	276
2017 Q2	$119K	Hold	2,216	–	–	0.05%	249
2017 Q1	$117K	Hold	2,216	–	–	0.05%	253
2016 Q4	$107K	Hold	2,216	–	–	0.05%	256
2016 Q3	$117K	Hold	2,216	–	–	0.06%	228
2016 Q2	$120K	Hold	2,216	–	–	0.07%	226
2016 Q1	$115K	Buy	+2,216	New	+$110K	0.07%	201

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Integrated Investment Consultants's GSK Position: Q4 2024 in Review

Integrated Investment Consultants sold out of GSK (GSK) in Q4 2024, closing a stake of 67,544 shares — an estimated $87K sold.

Integrated Investment Consultants first reported a position in GSK in Q1 2016 and held it in 13 quarters. The position peaked at $571K in Q2 2021. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

Integrated Investment Consultants reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
Integrated Investment Consultants sold 67,544 GSK shares in Q4 2024, an estimated $87K.
Integrated Investment Consultants first reported a position in GSK in Q1 2016 and held it in 13 quarters.
Integrated Investment Consultants's GSK position peaked at $571K in Q2 2021.
848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Integrated Investment Consultants's 13F filing for Q4 2024, filed 15 Jan 2025.